StockData
Evommune, Inc. logo

Evommune, Inc. (EVMN) stock

EVMNNYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30
$7.02−0.08 (-1.13%)

Close on Nov 17, 2026Market cap $254.77MP/E –Yield –

Evommune price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Evommune's price to sales ratio was 31.3× on Nov 11, 2026, against 2.5× a year earlier.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202631.3×+29.2
2025Dec 31, 20252.0×–

More Evommune figures

See a number that looks wrong?